Skip to content

PHARDA

Active
Private limited companyfounded 2001active for 25 yearsRue de la Providence 12, 6030 Charleroi, BelgiumKBO/BCE: BE 0474.979.207
Summary

PHARDA has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €336,326 and a net result of €113,407. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 73% of 4,961 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Register details

Identification
Legal formPrivate limited company
Founded13-06-2001
Financial year end30-09
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0474979207
Also 9925:BE0474979207
Registered 29-09-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 17 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Charleroiunit no. 2.098.276.779
1 permission
Apotheek (LM>3 maand) · since 14-09-2010

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Charleroi · 1 establishment unit since 2001
registered office establishment The establishment unit on the map
Ground area
779 m²
Building footprint
155 m²
Building volume
2,181 m³
Parcel 52382A0215/00A005, Wallonia · tallest building 15.7 m. Linked by address, not a title deed.
1 establishment unit
Rue de la Providence 12, 6030 Charleroi
Retail sale of pharmaceutical products
since 2001unit no. 2.098.276.779
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
52382A0215/00A005 Wallonia 779 m² 1 · 155 m² 15.7 m · 5
How the parcels are linked
Good to know
The parcel matches the address exactly.